The aim of this study was to evaluate the potential mechanisms underlying the improved contractility of the diaphragm (Dia) in adult intact male hamsters after nandrolone (Nan) administration, given subcutaneously over 4 wk via a controlled-release capsule (initial dose: 4.5 mg · kg¹ · day¹; with weight gain, final dose: 2.7 mg · kg¹ · day¹). Control (Ctl) animals received blank capsules. Isometric contractile properties of the Dia were determined in vitro after 4 wk. The maximum velocity of unloaded shortening (V_o) was determined in vitro by means of the slack test. Dia fibers were classified histochemically on the basis of myofibrillar ATPase staining and fiber cross-sectional area (CSA), and the relative interstitial space was quantitated. Ca²⁺-activated myosin ATPase activity was determined by quantitative histochemistry in individual diaphragm fibers. Myosin heavy chain (MHC) isoforms were identified electrophoretically, and their proportions were determined by using scanning densitometry. Peak twitch and tetanic forces, as well as V_o, were significantly greater in Nan animals compared with Ctl. The proportion of type IIa Dia fibers was significantly increased in Nan animals. Nan increased the CSA of all fiber types (26-47%), whereas the relative interstitial space decreased. The relative contribution of fiber types to total costal Dia area was preserved between the groups. Proportions of MHC isoforms were similar between the groups. There was a tendency for increased expression of MHC_2B with Nan. Ca²⁺-activated myosin ATPase activity was increased 35-39% in all fiber types in Nan animals. We conclude that, after Nan administration, the increase in Dia specific force results from the relatively greater Dia CSA occupied by hypertrophied muscle fibers, whereas the increased ATPase activity promotes a higher rate of cross-bridge turnover and thus increased V_o. We speculate that Nan in supraphysiological doses have the potential to offset or ameliorate conditions associated with enhanced proteolysis and disordered protein turnover.

anabolic-androgenic steroids; respiratory muscles; muscle specific force; muscle velocity of shortening; muscle fiber size; calcium activated-myosin adenosinetriphosphatase; myosin heavy chains

This article has been cited by other articles:

				M. I. Lewis, M. Fournier, T. W. Storer, S. Bhasin, J. Porszasz, S.-G. Ren, X. Da, and R. Casaburi Skeletal muscle adaptations to testosterone and resistance training in men with COPD J Appl Physiol, October 1, 2007; 103(4): 1299 - 1310. [Abstract] [Full Text] [PDF]

				M. I. Lewis, X. Da, H. Li, and M. Fournier Tumor necrosis factor-{alpha} and malnutrition-induced inhibition of diaphragm fiber growth in young rats J Appl Physiol, November 1, 2005; 99(5): 1649 - 1657. [Abstract] [Full Text] [PDF]

				W. Gao, P. J. Reiser, C. C. Coss, M. A. Phelps, J. D. Kearbey, D. D. Miller, and J. T. Dalton Selective Androgen Receptor Modulator Treatment Improves Muscle Strength and Body Composition and Prevents Bone Loss in Orchidectomized Rats Endocrinology, November 1, 2005; 146(11): 4887 - 4897. [Abstract] [Full Text] [PDF]

				F. Laghi, W. E. Langbein, A. Antonescu-Turcu, A. Jubran, C. Bammert, and M. J. Tobin Respiratory and Skeletal Muscles in Hypogonadal Men with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 598 - 605. [Abstract] [Full Text] [PDF]

				C. M. Kuhn Anabolic Steroids Recent Prog. Horm. Res., January 1, 2002; 57(1): 411 - 434. [Abstract] [Full Text] [PDF]

				C. E. Blanco, W.-Z. Zhan, Y.-H. Fang, and G. C. Sieck Exogenous testosterone treatment decreases diaphragm neuromuscular transmission failure in male rats J Appl Physiol, March 1, 2001; 90(3): 850 - 856. [Abstract] [Full Text] [PDF]

				P N R Dekhuijzen, H A Machiels, L M A Heunks, H F M van der Heijden, and R H H van Balkom Athletes and doping: effects of drugs on the respiratory system Thorax, November 1, 1999; 54(11): 1041 - 1046. [Full Text]

				M. I. Lewis, G. D. Horvitz, D. R. Clemmons, and M. Fournier Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E483 - E490. [Abstract] [Full Text] [PDF]